These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 6549362)

  • 21. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for radioiodine therapy (RIT) in benign thyroid diseases].
    Dietlein M; Dressler J; Joseph K; Leisner B; Moser E; Reiners C; Schicha H; Schneider P; Schober O
    Nuklearmedizin; 1999; 38(6A):219-20. PubMed ID: 10510811
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphology and function-based surgery in different forms of hyperthyroidism].
    Röher HD; Horster FA; Frilling A; Goretzki PE
    Chirurg; 1991 Mar; 62(3):176-81. PubMed ID: 1709844
    [No Abstract]   [Full Text] [Related]  

  • 26. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
    Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
    Burgos FL; Micames C; Rivera JV
    Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term results of radioiodine (131I) treatment in 331 patients with Graves' disease (author's transl)].
    Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1979 Jul; 68(7):724-32. PubMed ID: 113472
    [No Abstract]   [Full Text] [Related]  

  • 30. [The thyroid gland function at remote periods after I-131 treatment of patients with thyrotoxicosis].
    Dybovyĭ ED; Voronenko TV
    Probl Endokrinol (Mosk); 1967; 13(3):8-22. PubMed ID: 5633231
    [No Abstract]   [Full Text] [Related]  

  • 31. [Suppressibility of the thyroid function following radioiodine therapy of hyperthyroidism. When is Basedow-Graves disease completely cured?].
    Fazakas S; Kiss B; Petrányi G
    Orv Hetil; 1972 May; 113(20):1059-61. PubMed ID: 5067474
    [No Abstract]   [Full Text] [Related]  

  • 32. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of thyroid gland function using 125I during treatment of thyrotoxicosis with 131I].
    Livergant IuE
    Med Radiol (Mosk); 1976 Dec; 21(12):61-3. PubMed ID: 1025422
    [No Abstract]   [Full Text] [Related]  

  • 34. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 36. [Radioiodine therapy of recurrent hyperthyroidism in patients previously treated for diffuse toxic goiter with subtotal surgery].
    Vestergaard H; Laurberg P
    Ugeskr Laeger; 1993 Aug; 155(31):2403-5. PubMed ID: 8346592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
    Baczyk M; Junik R; Ziemnicka K; Sowiński J
    Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioiodine therapy for hyperthyroidism.
    Ross DS
    N Engl J Med; 2011 Feb; 364(6):542-50. PubMed ID: 21306240
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possible sequelae of the action of radioactive iodine in man].
    Il'in LA; Arkhangel'skaia GV
    Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.